
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
Arturo Casadevall, Quigly Dragotakes, Patrick W. Johnson, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 59
Arturo Casadevall, Quigly Dragotakes, Patrick W. Johnson, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 59
Showing 26-50 of 59 citing articles:
Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Convalescent Plasma in Critically ill Patients with Covid-19
Lise J Estcourt
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Lise J Estcourt
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Luther A. Bartelt, Alena J. Markmann, Bridget Nelson, et al.
mBio (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Mortality rates among hospitalized patients with COVID-19 treated with convalescent plasma A Systematic review and meta-analysis
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Jonathon W. Senefeld, Ellen K. Gorman, Patrick W. Johnson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7
David J. Sullivan, Arturo Casadevall
mBio (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 7
Outcome of SARS CoV-2 inpatients treated with convalescent plasma: One-year of data from the Veneto region (Italy) Registry
Giustina De Silvestro, Piero Marson, Massimo La Raja, et al.
European Journal of Internal Medicine (2021) Vol. 97, pp. 42-49
Open Access | Times Cited: 17
Giustina De Silvestro, Piero Marson, Massimo La Raja, et al.
European Journal of Internal Medicine (2021) Vol. 97, pp. 42-49
Open Access | Times Cited: 17
Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2
Tanushree Dangi, Sarah Sanchez, Min-Cheol Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Tanushree Dangi, Sarah Sanchez, Min-Cheol Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Convalescent plasma and COVID ‐19: Time for a second—second look?
Michael J. Joyner, Rickey E. Carter, DeLisa Fairweather, et al.
Transfusion Medicine (2022) Vol. 33, Iss. 1, pp. 16-20
Open Access | Times Cited: 10
Michael J. Joyner, Rickey E. Carter, DeLisa Fairweather, et al.
Transfusion Medicine (2022) Vol. 33, Iss. 1, pp. 16-20
Open Access | Times Cited: 10
The value of observational registry studies for the next infectious disease emergency
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile
Jeffrey M. Sturek, Tania A. Thomas, James D. Gorham, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Jeffrey M. Sturek, Tania A. Thomas, James D. Gorham, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 9
HemoClear: A Practical and Cost-Effective Alternative to Conventional Convalescent Plasma Retrieval Methods
Arno P. Nierich, Rosita Bihariesingh, Rakesh Bansie
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Arno P. Nierich, Rosita Bihariesingh, Rakesh Bansie
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Evidence for the Efficacy of COVID-19 Convalescent Plasma
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1207-1207
Open Access | Times Cited: 1
Massimo Franchini, Arturo Casadevall, Quigly Dragotakes, et al.
Life (2024) Vol. 14, Iss. 9, pp. 1207-1207
Open Access | Times Cited: 1
Misinterpretation of Clinical Research Findings and COVID-19 Mortality
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Arturo Casadevall, Liise-anne Pirofski
Annals of Internal Medicine (2023) Vol. 176, Iss. 7, pp. 993-994
Open Access | Times Cited: 4
Exercise and Experiments of Nature
Michael J. Joyner, Chad C. Wiggins, Sarah E. Baker, et al.
Comprehensive physiology (2023), pp. 4879-4907
Closed Access | Times Cited: 4
Michael J. Joyner, Chad C. Wiggins, Sarah E. Baker, et al.
Comprehensive physiology (2023), pp. 4879-4907
Closed Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Fabrice Cognasse, Hind Hamzeh‐Cognasse, Mickaël Rosa, et al.
EBioMedicine (2022) Vol. 87, pp. 104414-104414
Open Access | Times Cited: 7
Fabrice Cognasse, Hind Hamzeh‐Cognasse, Mickaël Rosa, et al.
EBioMedicine (2022) Vol. 87, pp. 104414-104414
Open Access | Times Cited: 7
COVID-19 infodemics: the role of mainstream and social media
Daniele Focosi, David Navarro, Fabrizio Maggi, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1568-1569
Open Access | Times Cited: 9
Daniele Focosi, David Navarro, Fabrizio Maggi, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 11, pp. 1568-1569
Open Access | Times Cited: 9
Finding evidence for treatment decisions in a pandemic
Nigel Paneth, Michael J. Joyner, Arturo Casadevall
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 536-541
Open Access | Times Cited: 4
Nigel Paneth, Michael J. Joyner, Arturo Casadevall
Trends in Molecular Medicine (2022) Vol. 28, Iss. 7, pp. 536-541
Open Access | Times Cited: 4
The Logic and History of Passive Immunity and Antibody Therapies
Arturo Casadevall, Nigel Paneth
Current topics in microbiology and immunology (2024)
Closed Access
Arturo Casadevall, Nigel Paneth
Current topics in microbiology and immunology (2024)
Closed Access
Updated Clinical Evaluation of the CLUNGENE® Rapid COVID-19 Antibody Test
Christopher C. Lamb, Fadi Haddad, Christopher Owens, et al.
Healthcare (2021) Vol. 9, Iss. 9, pp. 1124-1124
Open Access | Times Cited: 4
Christopher C. Lamb, Fadi Haddad, Christopher Owens, et al.
Healthcare (2021) Vol. 9, Iss. 9, pp. 1124-1124
Open Access | Times Cited: 4
The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
Nigel Paneth, Arturo Casadevall, Michael J. Joyner
Health Science Reports (2023) Vol. 6, Iss. 8
Open Access | Times Cited: 1
Nigel Paneth, Arturo Casadevall, Michael J. Joyner
Health Science Reports (2023) Vol. 6, Iss. 8
Open Access | Times Cited: 1
Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19
Elvira Maličev, Klemen Žiberna, Katerina Jazbec, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 51, Iss. 3, pp. 175-184
Open Access | Times Cited: 1
Elvira Maličev, Klemen Žiberna, Katerina Jazbec, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 51, Iss. 3, pp. 175-184
Open Access | Times Cited: 1
Has plasma therapy failed in Covid-19 or we have failed in using it properly in India?–Lessons learned through the pandemic
Suvro Sankha Datta, Ritam Chakrabarty
Transfusion Clinique et Biologique (2021) Vol. 29, Iss. 1, pp. 92-93
Open Access | Times Cited: 3
Suvro Sankha Datta, Ritam Chakrabarty
Transfusion Clinique et Biologique (2021) Vol. 29, Iss. 1, pp. 92-93
Open Access | Times Cited: 3
Using automation to manage donor engagement and fine-tune supply and demand during the first year of the COVID-19 pandemic
Theresa Pina, Marc S. Lewis, Charity Garrison, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 4, pp. 103420-103420
Open Access | Times Cited: 2
Theresa Pina, Marc S. Lewis, Charity Garrison, et al.
Transfusion and Apheresis Science (2022) Vol. 61, Iss. 4, pp. 103420-103420
Open Access | Times Cited: 2